As a global organization that is fuelled by research and a commitment to advancing science, Roche recognizes the value of bringing innovation to patients who may not have other treatment options available to them. Our commitment to the future of medicine hinges on our ability to invest and reinvest in countries, markets and communities that offer fertile ground for this research.
The Roche Global Product Development site in Mississauga is one of five product development sites within the Roche global community. In August 2011, Roche invested more than $190 million into expanding the Mississauga site. In this time, the site has grown from approximately 60 employees to more than 400 employees with highly skilled and specialized roles, including a presence in our global biometrics, regulatory, and clinical operations functions. These colleagues contribute to all phases of
In 2017, Roche invested over $52 million in
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
You are now leaving the website of Hoffmann-La Roche Ltd. ("Roche Canada"). Links to all external sites are provided as a resource to our visitors. Roche Canada assumes no responsibility for the content of these sites. Roche Canada has no control over these sites and the opinions, claims or comments contained in these sites should not be attributed to Roche Canada, unless otherwise specified.